Literature DB >> 34089030

WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic.

Smriti Mallapaty.   

Abstract

Entities:  

Keywords:  Diseases; SARS-CoV-2; Vaccines

Year:  2021        PMID： 34089030     DOI： 10.1038/d41586-021-01497-8

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  15 in total

1.  [Approval of CoronaVac in Brazil and Chile: some lessons on vaccine regulatory challengesA aprovação da CoronaVac no Brasil e no Chile: algumas lições sobre os desafios regulatórios de vacinas].

Authors:  Ana Sojo
Journal:  Rev Panam Salud Publica       Date:  2022-07-20

2.  Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome.

Authors:  Flavio Signorelli; Gustavo Guimarães Moreira Balbi; Nadia E Aikawa; Clovis A Silva; Léonard de Vinci Kanda Kupa; Ana C Medeiros-Ribeiro; Emily Fn Yuki; Sandra G Pasoto; Carla Gs Saad; Eduardo F Borba; Luciana Parente Costa Seguro; Tatiana Pedrosa; Vitor Antonio de Angeli Oliveira; Ana Luisa Cerqueira de Sant'Ana Costa; Carolina T Ribeiro; Roseli Eliana Beseggio Santos; Danieli Castro Oliveira Andrade; Eloisa Bonfá
Journal:  Lupus       Date:  2022-05-20       Impact factor: 2.858

3.  Effectiveness of the CoronaVac® vaccine in a region of the Colombian Amazon, was herd immunity achieved?

Authors:  Héctor Serrano-Coll; Hollman Miller; Camilo Guzmán; Ricardo Rivero; Bertha Gastelbondo; Jorge Miranda; Ketty Galeano; Jhon Montaña-Restrepo; Salim Mattar
Journal:  Trop Dis Travel Med Vaccines       Date:  2022-01-15

4.  Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days.

Authors:  Qiu-Yan Xu; Jian-Hang Xue; Yao Xiao; Zhi-Juan Jia; Meng-Juan Wu; Yan-Yun Liu; Wei-Li Li; Xian-Ming Liang; Tian-Ci Yang
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

5.  Transmission and containment of the SARS-CoV-2 Delta variant of concern in Guangzhou, China: A population-based study.

Authors:  Li Li; Zhi-Gang Han; Peng-Zhe Qin; Wen-Hui Liu; Zhou Yang; Zong-Qiu Chen; Ke Li; Chao-Jun Xie; Yu Ma; Hui Wang; Yong Huang; Shu-Jun Fan; Ze-Lin Yan; Chun-Quan Ou; Lei Luo
Journal:  PLoS Negl Trop Dis       Date:  2022-01-05

Review 6.  The intestinal microbiota and improving the efficacy of COVID-19 vaccinations.

Authors:  Jiezhong Chen; Luis Vitetta; Jeremy D Henson; Sean Hall
Journal:  J Funct Foods       Date:  2021-11-10       Impact factor: 4.451

Review 7.  Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines.

Authors:  Yandi Zhang; Jo-Lewis Banga Ndzouboukou; Mengze Gan; Xiaosong Lin; Xionglin Fan
Journal:  Front Immunol       Date:  2021-11-22       Impact factor: 7.561

8.  EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes.

Authors:  Cristina S Ferreira; Yasmmin C Martins; Rangel Celso Souza; Ana Tereza R Vasconcelos
Journal:  PeerJ       Date:  2021-11-30       Impact factor: 2.984

9.  Inactivated Whole-virus Vaccine Triggers Low Response Against SARS-CoV-2 Infection Among Renal Transplant Patients: Prospective Phase 4 Study Results.

Authors:  José Medina-Pestana; Dimas Tadeu Covas; Laila Almeida Viana; Yasmim Cardoso Dreige; Monica Rika Nakamura; Elizabeth França Lucena; Lucio R Requião-Moura; Carlos Magno Castelo Branco Fortaleza; Renato Demarchi Foresto; Helio Tedesco-Silva; Marina Pontello Cristelli
Journal:  Transplantation       Date:  2022-04-01       Impact factor: 4.939

10.  Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy.

Authors:  Cengiz Karacin; Tulay Eren; Esra Zeynelgil; Goksen Inanc Imamoglu; Mustafa Altinbas; Ibrahim Karadag; Fatma Bugdayci Basal; Irem Bilgetekin; Osman Sutcuoglu; Ozan Yazici; Nuriye Ozdemir; Ahmet Ozet; Yesim Yildiz; Selin Akturk Esen; Gokhan Ucar; Dogan Uncu; Bedia Dinc; Musa Baris Aykan; İsmail Erturk; Nuri Karadurmus; Burak Civelek; İsmail Çelik; Yakup Ergun; Mutlu Dogan; Omur Berna Oksuzoglu
Journal:  Future Oncol       Date:  2021-08-03       Impact factor: 3.404
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.